Skip to content

The efficacy and safety of microecological intervention in the prevention and treatment of chemotherapy associated side effects among breast cancer patients

The efficacy and safety of microecological intervention in the prevention and treatment of chemotherapy associated side effects among breast cancer patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048574
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Experimental group:Probiotic solid drink
Control group:Placebo solid drink

Sponsors

Tangshan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed breast cancer patients who are planning to undergo chemotherapy; 2. Aged 20 to 60 years; 3. No immune system disease; 4. Agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Suffering from refractory oral ulcers, psoriasis, eczema, tinea pedis and other skin diseases, and other diseases that may cause skin damage (such as syphilis, etc.); 2. Suffering from severe gastrointestinal diseases (such as gastrointestinal ulcers, gastrointestinal perforation, ulcerative colitis, irritable bowel syndrome, etc.); 3. Those with coronary heart disease, myocardial infarction and extremely poor heart function; 4. Participating in other clinical trials; 5. Patients with severe liver and kidney disease; 6. Suffering from dementia (defined as MMSE score <= 2 points) or Parkinson's disease or other neurological diseases that cause dysfunction, as well as a history of traumatic brain injury, cerebral hemorrhage, stroke, brain tumor, cerebral infarction, etc.; 7. Advanced patients or patients with other malignant tumors; 8. Those who have mental illness or have a family history of mental illness; 9. Patients who are addicted to alcohol or drugs; 10. Those who refuse to join the group and cannot cooperate with the treatment; 11. The attending doctor or the researcher believes that there are other circumstances that are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
side effects;

Secondary

MeasureTime frame
Gut microbiota;

Countries

China

Contacts

Public ContactZhang Juan

Tangshan Central Hospital

17877272@qq.com+86 13393159122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026